Miguel Sanz

Full Professor - Honorary Professor

University of Valencia

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

ISABEL CANO FERRI

Instituto de Investigación Sanitaria La Fe

SPAIN

View details

Javier Marco-Ayala

Universidad de Murcia

SPAIN

View details

Rebeca Rodríguez-Veiga

Instituto de Investigación Sanitaria La Fe

SPAIN

View details

María-Belén Vidriales

Universidad de Salamanca

SPAIN

View details

Juan Manuel Alonso-Dominguez

Universidad Autónoma de Madrid

SPAIN

View details

Alicia Roldán Pérez

Universidad Europea de Madrid SLU

SPAIN

View details

Antonio Rosal-Vela

Profesor Sustituto Interino

Universidad de Cádiz

SPAIN

View details

MJ Calasanz

Full Professor of Genetics

Universidad de Navarra

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miguel Sanz

Research Interests

Explore related searches

Contact this professor

Articles (11)

Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience

PCR-Based Strategy for Introducing CRISPR/Cas9 Machinery into Hematopoietic Cell Lines

Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution

Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia

IMPACT OF POSTTRANSPLANT CYCLOPHOSPHAMIDE ON TRANSFUSION REQUIREMENTS IN HLA MATCHED SIBLING PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory <i>FLT3</i>-ITD Mutation-Positive Acute Myeloid Leukemia

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry

Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Collaborators (8)

ISABEL CANO FERRI

Javier Marco-Ayala

Rebeca Rodríguez-Veiga

María-Belén Vidriales

Juan Manuel Alonso-Dominguez

Alicia Roldán Pérez

Antonio Rosal-Vela

MJ Calasanz

Make your next move.

Miguel Sanz

Research Interests

Explore related searches

Contact this professor

Articles (11)

Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience

PCR-Based Strategy for Introducing CRISPR/Cas9 Machinery into Hematopoietic Cell Lines

Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution

Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia

IMPACT OF POSTTRANSPLANT CYCLOPHOSPHAMIDE ON TRANSFUSION REQUIREMENTS IN HLA MATCHED SIBLING PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory <i>FLT3</i>-ITD Mutation-Positive Acute Myeloid Leukemia

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry

Healthcare Resource Utilization among Patients between 60&ndash;75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Collaborators (8)

ISABEL CANO FERRI

Javier Marco-Ayala

Rebeca Rodríguez-Veiga

María-Belén Vidriales

Juan Manuel Alonso-Dominguez

Alicia Roldán Pérez

Antonio Rosal-Vela

MJ Calasanz

Make your next move.

Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study